
News|Articles|December 2, 2004
- Pharmaceutical Technology-12-02-2004
- Volume 28
- Issue 11
In Between the Light and the Dark: Developments in Photosensitive Pharmaceuticals
Researchers are improving photodynamic therapies with new photosensitizers and light sources for deeper tissue penetration, more site-specific treatments, and reduced side effects.
Advertisement
Articles in this issue
over 21 years ago
In the Spotlight-December 2004over 21 years ago
Safety Problems Roil Pharma and FDAover 21 years ago
December 2004over 21 years ago
Robust CRO Market Is Driving New Merger and Acquisition Activityover 21 years ago
The Seventh Annual International Employment Surveyover 21 years ago
Pharmaco-FakeryAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup—July 24, 2026
2
What Jideytro's Approval Means for Drug Developers
3
Peptide Compounding Vote Raises New Questions for Drug Developers
4
Midyear 2026 Check In: Campbell Bunce of Abzena Talks Antibody-Oligonucleotide Conjugates and Development Timelines
5




